Axcella Health Inc.
DelistedCIK 1633070fmd_0S8VXSVDY98DH6STVADX980EVEManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2017 to Jun 30, 2023, 23 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Research and development | – | 25 | 42 | 37 | 43 | 57 |
| Total operating expenses | – | 34 | 57 | 54 | 62 | 77 |
| Operating income | – | (34) | (57) | (54) | (62) | (77) |
| Interest expense | – | 3 | 3 | 3 | 3 | 3 |
| Other non-operating income (expense) | – | (2) | (2) | (3) | (3) | (4) |
| Net income | (59) | (36) | (59) | (57) | (65) | (81) |
| Net income to common shareholders | – | (36) | (59) | (57) | – | – |